| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 303.4 | 281.8 | 245.7 |
| Other income | 8.0 | 7.5 | 3.9 |
| Total income | 311.4 | 289.2 | 249.6 |
| Profit before exceptional items & tax | 44.3 | 44.6 | -0.6 |
| Profit before tax | 40.4 | 41.0 | -0.6 |
| Net profit | 33.5 | 32.0 | -9.5 |
| Operating margin | 13.0% | 14.2% | -0.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +4.70% |
|---|---|
| Revenue, year on year | +23.50% |
| Operating profit, year on year | +906.70% |
| Operating profit, quarter on quarter | -2.20% |
NSE results filing, NSE: NEPHROPLUS. Figures extracted from the filing.
Nephrocare Health Services Ltd: key numbers
- Share price
- ₹624.60
- Market cap
- ₹6,267 Cr
- Revenue (annual)
- ₹998.8 Cr
- Net profit (annual)
- ₹76.84 Cr
- P/E (TTM)
- 73.6×Sector 53.7×
- Promoter holding
- 58.31%-5.54% QoQ
- FII holding
- 11.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nephrocare Health Services Ltd
All →Nephrocare Health Services Other Announcement
Nephrocare filed Crisil's monitoring agency report on IPO proceeds for the quarter ended 30 September 2026. The report shows no deviation from the stated objects.
Nephrocare Health Services Investor Presentation: Key Takeaways
H1FY27 revenue ₹585.2 Cr (+23.6% YoY), Adj EBITDA ₹134.4 Cr (+15.3%), Adj PAT ₹76.1 Cr (+34.7%). Expansion via acquisitions in Philippines, Kazakhstan and Saudi Arabia.
Nephrocare Health Services Results Update
Nephrocare Health Services released its Q2 and H1 FY27 results press release. Revenue and adjusted profit grew year-on-year, alongside network expansion into Kazakhstan.
Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Nephrocare Health Services Acquisition
Nephrocare's Philippines subsidiary agreed to acquire dialysis center assets from JCM Summit Health under an Asset Transfer Agreement. Consideration is undisclosed but the deal exceeds materiality thresholds.
Nephrocare Health Services Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).